We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Udg Healthcare Public Limited Company | LSE:UDG | London | Ordinary Share | IE0033024807 | ORD EUR0.05 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,079.00 | 1,078.00 | 1,079.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/4/2007 08:51 | I think that there are a number of things holding this back: 1) The pricing agreement 2) A bad year last year due to the Magna park move ( although the underlying figures were as expected ) 3) No figures with the last trading statement 4) Also perhaps the popularity of margin trading ( spreadbets, CFD's etc ) allowing this to become a trading share with larger 'swings' 5) The multiple it trades on is also quiet high which may put some people off As a long term play I am not too worried. :O) | liarspoker | |
04/4/2007 08:19 | Have been watching this share on and off for 12 months now and should have bought last October. However I finally got around to buying a chunk this week in anticipation of a positve trading update. The statement looks good to me but as I write the price has dropped back this morning. Could you longer term holders shed any light on what's holding this back. To me this deserves a rerating! | foxman14 | |
30/3/2007 22:36 | Ageing population the reason i was attracted to the stock. I bouught udg 2 years ago in college when studying macro economics. Irelands ageing population is of course unique. Take your point about capex in relation to magna park but it has helped margins. I personally would like to see UDG move into other high margin areas in outsourcing. For instance Newcourt bought a recruitment firm today that specialises in recruiting doctors, nurses and medical professionals. Recruitment margins are through the roof. Packaging appears to be high on the agenda i think. Whats your opinion. Would you like to see a move into higher margin areas and what? | slasher16 | |
30/3/2007 21:40 | Indeed Slasher - just remember that there has been a lot of capex with the office move but this should hold them in good stead in the future.Also, and I keep saying it, Irelands expanding and aging population should bode well in the future. BTW 270p resistance can be seen here: | liarspoker | |
30/3/2007 12:11 | Ya goin by the price of the new offer for Alliance boots from private equity at 22.6 times last years earnings UDG should be bout 450 with EPS at 20cent. Finding it hard to break through the 270sterling mark or 4 mark. Weve shown resistance bout ten times now. All in all a goog trading statement next wk may be key to a move to say 4.40 and a breakout. Doesnt really matter to me though as at 24 this is a 40year investment, Aka Lifer to you Liars, for me as long as they keep producing the goods as they have!! | slasher16 | |
29/3/2007 15:08 | Interesting price movement of late. I think that we'll see a new high shortly. :O) | liarspoker | |
27/3/2007 21:03 | I think that if indeed there was a pennant that we are breaking out of it now. Of course I mainly go on fundies so am not a chartist at all, I only use charts to time my buys and sells. Perhaps todays rise is due to some good news which will be included in H1 results. I am content to hold on to my UDG shares. | liarspoker | |
26/3/2007 19:28 | Well Liars, Long time no talk. See u talkin bout a pennant there mate. Do u think we could down to 2.40 pounds.If we do id definetly do a CFD for a rebound back to test 270. Fundemntals and technicals would b totally in gear. Wats ur thinkin on the charts pro? | slasher16 | |
23/3/2007 11:45 | look at this RNS in the medical world Mediwatch says develops rapid prostate cancer test, approved across Europe - Medical diagnostic equipment maker Mediwatch PLC said it developed a new test to detect the presence of prostate cancer in 10 minutes. The company said the test, called PSAwatch, has already been approved in alL countries across Europe and that it expects approval in other countries shortly. Mediwatch said the test saves time for doctors and patients and is much cheaper to operate than existing tests. newsdesk@afxnews.com rda/tc | onehanded | |
23/3/2007 11:32 | Pennant still in progress ( if indeed it is a pennant ). :O) I wish that they had included figures in the last trading statement. We could well be in for a bout of volatility soon ( sort of what we have seen in the last 2 years ). | liarspoker | |
16/3/2007 13:53 | Another swap of 3.6 million shares - interesting. | liarspoker | |
15/3/2007 12:17 | Looks like a pennant is forming on the graph. Actually I just wanted to post that I am really not happy with the new accounting layout in the 2006 annual report. I am just doing some ratios and imo the layout in 2004/2005 was much clearer. Bloody IFRS - pain in the butt !!! | liarspoker | |
14/3/2007 17:07 | Interesting. My monitor has UDG Green but with the last trade occuring at 13:25. Yet the graph above shows us that we are Blue ?!?! Strange. | liarspoker | |
14/3/2007 16:50 | Nice to see a blue spot in a column of red this afternoon.A good sign imo. Steady she goes. | what is a login ? | |
02/3/2007 15:15 | Received my Scrip forms today. :O) | liarspoker | |
27/2/2007 23:34 | I totally agree with you. Il b keeping my long term holding too.wd b moving higher though to say 4.50 only for the mkt isnt sure if we can maintain 15% growth due to pricing agreement.I think we can.We will have to see at interim time though.The stratgy is to grow the business in higher margin areas. Our balance sheet is nicely setup for acquisitions too. | slasher16 | |
27/2/2007 22:12 | This years drug pricing agreement and the one next year have been factored into the price imo. If they weren't then the share price would have been higher over the last year instead of peaking at 260p everytime. Word from the street has it that UDG will continue to grow EPS at about 10% per annum after the drug pricing agreements are implemented. I'll be keeping my long term holding anyway so we'll find out if I was right or wrong in 20 years. | liarspoker | |
27/2/2007 12:26 | United Drug AGM Chairman's Statement RNS Number:9270R United Drug PLC 27 February 2007 United Drug plc Annual General Meeting Chairman's Statement I am pleased to report that United Drug has made a good start to the year with profits in the first quarter ahead of the same period last year. In March the first phase of the Irish Government review of the drug pricing agreement will take effect with a reduction in the price of off patent branded medicines. We have robust plans in place to manage this process. Our new acquisitions are performing ahead of expectations and we expect to make further progress during the year with our strategy of developing United Drug into a broadly based healthcare services group. Against this background we look forward to another successful year of growth. Ronnie Kells Chairman New acquisitions performing ahead of expectations. EPS up by +- 15% again ? | liarspoker | |
14/2/2007 19:16 | Hi Liars, Check out what i am sayin bout Newcourt on the latest thrad their. Do u track them? | slasher16 | |
13/2/2007 18:51 | Nothing wrong with it man. Im only out of colllege 18 months sure with a Business degree. | slasher16 | |
13/2/2007 13:50 | Business - Ha ha ha....sad but true. | liarspoker | |
13/2/2007 13:06 | Ya d mkt is toppy alrite mate. Il be keepin my cash for lifers too when we see the end of this bull run. Maybe Kingspan, Anglo, BOI & United Drug!!! Warren Buffett styling!! Wat u studying for kid? | slasher16 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions